介乐金-37:在自体主导多囊性病中是一种新的治疗标

Bo Yang1, Steven D Crowley2

  • 1Division of Nephrology and Endocrinology, Naval Medical Center of PLA, Naval Medical University, Shanghai, People's Republic of China.

Kidney international
|March 22, 2024
PubMed
概括

介质素-37是一种新型细胞因子,通过激活中的免疫细胞来抑制自体主导多囊性病 (ADPKD) 的发病. 这一发现突出了ADPKD潜在的新疗法.